Nipro Corp - Company Profile
Powered by
All the data and insights you need on Nipro Corp in one report.
- Save hours of research time and resources with
our up-to-date Nipro Corp Strategy Report
- Understand Nipro Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Nipro Corp (Nipro) develops, manufactures and commercializes pharmaceuticals, medical equipment and functional materials including glass, rubber and plastic products. The company’s products include renal products, interventional and anaesthesiology products, injection and infusion products, cardiopulmonary products, double bags, pre-filled syringes, and half-type kits among others. It offers contract manufacturing services of development, manufacturing of drug formulations, inspection, packaging, logistics and distribution services. Nipro also provides glass molding vials, ampoules, syringes, and cartridges; glass tubes for pharmaceuticals; glass-forming machinery; other parts of pharmaceutical packaging including rubber plugs; and glass bulbs for vacuum flasks. The company has sales offices in North America, South America, Europe, Asia and Africa. Nipro is headquartered in Settsu, Osaka, Japan.
Nipro Corp premium industry data and analytics
Products and Services
Products | Services | Brands |
---|---|---|
Medical-Related | Service: | PFS |
Renal | Contract Manufacturing Services | PLW |
Dialysis Machine | ||
XYZ | ||
XYZ | ||
XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Contracts/Agreements | In July, the company signed a syndicated arrangement with The Nochu Trust and Banking Co. to solve social issues. |
2023 | Contracts/Agreements | In February, Nipro Medical Europe announced to collaborate with Prevas to conduct a comprehensive UX study of their medical devices and to choose new design concept. |
2023 | Regulatory Approval | In February, the company was awarded manufacturing and marketing approval in Japan for three products with one generic drug ingredient. |
Competitor Comparison
Key Parameters | Nipro Corp | Fresenius SE & Co KGaA | Chugai Pharmaceutical Co Ltd | Terumo Corp | Mitsubishi Tanabe Pharma Corp |
---|---|---|---|---|---|
Headquarters | Japan | Germany | Japan | Japan | Japan |
City | Settsu-Shi | Bad Homburg | Chuo-Ku | Shibuya-Ku | Osaka |
State/Province | Osaka | Hessen | Tokyo | Tokyo | Osaka |
No. of Employees | 38,770 | 193,865 | 7,771 | 30,207 | 6,697 |
Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Yoshihiko Sano | Director; President | Executive Board | 2006 | - |
Kiyotaka Yoshioka | Managing Director | Senior Management | 2006 | - |
Kenichi Nishida | Managing Director | Senior Management | 2010 | - |
Yasushi Ohyama | Managing Director | Senior Management | - | - |
Kazuhiko Sano | Managing Director | Senior Management | 2010 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward